U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06848842) titled 'Ivonescimab Plus Chemotherapy in Patients with Initially Unresectable Colorectal Cancer Liver Metastases' on Feb. 06.
Brief Summary: The goal of this clinical trial is to learn if ivonescimab plus chemotherapy works to treat colorectal cancer liver metastases that cannot be completely removed. It will also learn about the safety of ivonescimab. The main questions it aims to answer are:
Does ivonescimab plus chemotherapy raise the objective response rate? What medical problems do participants have when receiving ivonescimab plus chemotherapy?
Participants will:
Receive ivonescimab and chemotherapy every 3 weeks, no more than 8 cyc...